Published in Expert Opin Investig Drugs on October 03, 2013
Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes. Clin Ophthalmol (2015) 0.84
α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways. Sci Rep (2015) 0.79
Comparison of cytotoxicity and wound healing effect of carboxymethylcellulose and hyaluronic acid on human corneal epithelial cells. Int J Ophthalmol (2015) 0.79
In pursuit of objective dry eye screening clinical techniques. Eye Vis (Lond) (2016) 0.78
Effects of exogenous recombinant human bone morphogenic protein-7 on the corneal epithelial mesenchymal transition and fibrosis. Int J Ophthalmol (2017) 0.75
The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study. Biomed Res Int (2016) 0.75
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
Modified double-K method for intraocular lens power calculation after excimer laser corneal refractive surgery. J Cataract Refract Surg (2013) 3.29
The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci (2011) 2.66
Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2006) 2.40
The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci (2011) 2.28
No forward shifting of posterior corneal surface in eyes undergoing LASIK. Ophthalmology (2007) 2.21
Topography-guided conductive keratoplasty: treatment for advanced keratoconus. Am J Ophthalmol (2010) 2.10
Ocular surface changes with applanation contact lens and coupling fluid use after argon laser photocoagulation in noninsulin-dependent diabetes mellitus. Am J Ophthalmol (2004) 2.06
Impaired functional visual acuity of dry eye patients. Am J Ophthalmol (2002) 1.94
The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci (2011) 1.80
The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol (2005) 1.74
The effect of periocular warming on accommodation. Ophthalmology (2005) 1.74
New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology (2007) 1.71
Oxidative stress induced inflammation initiates functional decline of tear production. PLoS One (2012) 1.64
Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology (2008) 1.61
Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Invest Ophthalmol Vis Sci (2007) 1.59
Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol (2007) 1.54
Mathematical projection model of visual loss due to fuchs corneal dystrophy. Invest Ophthalmol Vis Sci (2011) 1.53
Cytokeratin 15 can be used to identify the limbal phenotype in normal and diseased ocular surfaces. Invest Ophthalmol Vis Sci (2006) 1.53
Noninvasive interference tear meniscometry in dry eye patients with Sjögren syndrome. Am J Ophthalmol (2007) 1.51
Isolation of multipotent neural crest-derived stem cells from the adult mouse cornea. Stem Cells (2006) 1.49
Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology (2004) 1.48
Biological effects of blocking blue and other visible light on the mouse retina. Clin Experiment Ophthalmol (2013) 1.46
Subjective visual sensation during vitrectomy under retrobulbar anesthesia. Am J Ophthalmol (2006) 1.46
The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br J Ophthalmol (2010) 1.43
Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology (2011) 1.43
Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study. Int J Urol (2013) 1.41
The features of dry eye disease in a Japanese elderly population. Optom Vis Sci (2006) 1.41
Tear function and ocular surface findings in premature and term babies. Ophthalmology (2004) 1.41
Ocular integrity after anterior ciliary sclerotomy and scleral ablation by the Er:YAG laser. J Refract Surg (2005) 1.41
Effect of age on changes in anterior chamber depth and volume after laser in situ keratomileusis. J Cataract Refract Surg (2009) 1.41
Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol (2004) 1.40
Microkeratome-assisted phacoemulsification. J Cataract Refract Surg (2005) 1.38
Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study. Am J Ophthalmol (2013) 1.37
Laboratory findings in tear fluid analysis. Clin Chim Acta (2006) 1.36
Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology (2002) 1.35
Beta-catenin activation and epithelial-mesenchymal transition in the pathogenesis of pterygium. Invest Ophthalmol Vis Sci (2007) 1.30
Randomized clinical trial of deep lamellar keratoplasty vs penetrating keratoplasty. Am J Ophthalmol (2002) 1.30
A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients. Br J Ophthalmol (2012) 1.29
Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation. Proc Natl Acad Sci U S A (2003) 1.28
Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. Invest Ophthalmol Vis Sci (2009) 1.25
Deep anterior lamellar keratoplasty. Curr Opin Ophthalmol (2006) 1.25
Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. Invest Ophthalmol Vis Sci (2007) 1.24
Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Invest Ophthalmol Vis Sci (2006) 1.24
(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes (2009) 1.24
Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization. Am J Pathol (2007) 1.23
The application of a new continuous functional visual acuity measurement system in dry eye syndromes. Am J Ophthalmol (2005) 1.21
Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci (2008) 1.21
Serum-free spheroid culture of mouse corneal keratocytes. Invest Ophthalmol Vis Sci (2005) 1.20
Intrinsic signal imaging in macaque retina reveals different types of flash-induced light reflectance changes of different origins. Invest Ophthalmol Vis Sci (2007) 1.20
Report of the TFOS/ARVO Symposium on global treatments for dry eye disease: an unmet need. Ocul Surf (2012) 1.19
Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes (2008) 1.19
Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci (2005) 1.18
The application of in vivo laser confocal microscopy to the diagnosis and evaluation of meibomian gland dysfunction. Mol Vis (2008) 1.18
INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model. J Ocul Pharmacol Ther (2002) 1.18
Tearful relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol (2009) 1.18
Dietary restriction: standing up for sirtuins. Science (2010) 1.17
Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci (2007) 1.17
Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol (2007) 1.16
A new mouse model of dry eye disease: oxidative stress affects functional decline in the lacrimal gland. Cornea (2012) 1.14
Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest Ophthalmol Vis Sci (2003) 1.14
Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci (2006) 1.14
Transcorneal electrical stimulation of retina to treat longstanding retinal artery occlusion. Graefes Arch Clin Exp Ophthalmol (2007) 1.13
Carbon-ion radiation therapy for prostate cancer. Int J Urol (2012) 1.13
A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Jpn J Clin Oncol (2006) 1.13
Functional corneal endothelium derived from corneal stroma stem cells of neural crest origin by retinoic acid and Wnt/β-catenin signaling. Stem Cells Dev (2012) 1.12
Autologous serum eye drops for the treatment of dry eye diseases. Cornea (2008) 1.12
Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol (2003) 1.12
Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Arterioscler Thromb Vasc Biol (2006) 1.12
Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin-proteasome-dependent degradation of rhodopsin during retinal inflammation. J Biol Chem (2008) 1.11
Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology (2002) 1.11
Association between meibomian gland changes and aging, sex, or tear function. Cornea (2006) 1.10
Long-term culture and growth kinetics of murine corneal epithelial cells expanded from single corneas. Invest Ophthalmol Vis Sci (2009) 1.10
The role of oxidative stress and inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci (2009) 1.09
Massive bilateral vitreoretinal hemorrhage in patient with chronic refractory idiopathic thrombocytopenic purpura. Graefes Arch Clin Exp Ophthalmol (2005) 1.09
Concept of functional visual acuity and its applications. Cornea (2007) 1.09
The application of in vivo confocal scanning laser microscopy in the management of Acanthamoeba keratitis. Mol Vis (2007) 1.08
Smoking associated with damage to the lipid layer of the ocular surface. Am J Ophthalmol (2006) 1.08
The contribution of the posterior surface to the corneal aberrations in eyes after keratoplasty. Invest Ophthalmol Vis Sci (2011) 1.08
Application of visante optical coherence tomography tear meniscus height measurement in the diagnosis of dry eye disease. Ophthalmology (2010) 1.07
Long-term outcome of cultivated oral mucosal epithelial sheet transplantation in treatment of total limbal stem cell deficiency. Ophthalmology (2011) 1.07
Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction. Cornea (2006) 1.07
Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am J Pathol (2008) 1.07
Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. Ophthalmology (2012) 1.07
Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. Invest Ophthalmol Vis Sci (2003) 1.06
Factors influencing outcomes in cultivated limbal epithelial transplantation for chronic cicatricial ocular surface disorders. Am J Ophthalmol (2007) 1.06